Ainshams University
Cairo, 4393005, Egypt
NCT Number: NCT05496608
For patients having periodontal intrabony lesions, three treatment modalities were executed to evaluate the effect of protecting Leukocyte rich -Platelet Rich Fibrin harvests (applied in the bony defects) with resorbable collagen membranes. Clinical Outcomes recorded were the Plaque index (PI), Gingival index (GI), probing depth reduction (PD), Clinical attachment level (CAL), and radiographic defect depth changes.
For the biochemical evaluation: levels of PDGF-BB and VEGF obtained from crevicular fluid by Perio-Paper strips were assessed using ELIZA.
Looking for future studies?
Notify Me30 year–50 year
All sexes
Interventional
Not applicable
Cairo, 4393005, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a blood sample is obtained from the patient, and centrifuged to prepare a leukocyte platelet rich fibrin harvest that is applied within the derided lesion.
Other names: Leukocyte platelet rich fibrin
Full thickness flap elevation to gain access to the infrabony lesion for debridement followed by flap closure.
Other names: Open flap Debridement
Xenogeneic collagen membranes that are used as barrier membranes in guided tissue regeneration of periodontal defects
Other names: Collagen membrane
Time frame: 6 months
measures the score of gingival inflammation. Minimum value of 0: denotes absence of inflammation. Maximum value = 3 and denotes severe inflammation
Time frame: 6 months
measures the score of plaque accumulation. Minimum value of 0: denotes absence of plaque on teeth surfaces. Maximum value = 3 and denotes diffuse and abundant plaque accumulation on teeth surfaces
Time frame: 6 months
measures the reduction in pocket depth
Time frame: 6 months
measures the changes in amount of periodontal attachment
Time frame: 6 months
measures the changes in bone defect depth
Time frame: 6 months
measures the amount of crystal bone changes
Time frame: 31 days
Biochemical Evaluation of changes in levels of crevicular Platelet Derived Growth Factor -BB
Time frame: 31 days
Biochemical Evaluation of changes in levels of crevicular Vascular endothelial growth factor
Future University in Egypt
Other
Treatment of Periodontal Intrabony Defects With Dense Leukocyte and Platelet-Rich Fibrin (L-PRF) Membrane Alone or in Combination With Collagen Membranes (Randomized Clinical and Biochemical Trial)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07697209
Alveolar Bone Loss, Bone Diseases
Al Mansurah, Egypt
View Trial DetailsNCT07310732
Alveolar Bone Loss, Bone Diseases
Bhilai, Chhattisgarh, India
View Trial DetailsNCT03264118
Alveolar Bone Loss, Bone Diseases
Bauru, São Paulo, Brazil
View Trial DetailsNCT05631600
Alveolar Bone Loss, Bone Diseases
Zagreb, Croatia
View Trial Details